| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...748839M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0048839 |
| P8608 | Fatcat ID | release_emfpgi7cxzg6bb53khnnsja42m |
| P932 | PMC publication ID | 3492258 |
| P698 | PubMed publication ID | 23144991 |
| P5875 | ResearchGate publication ID | 233397120 |
| P50 | author | Mark A Boyd | Q61799658 |
| P2093 | author name string | Kathy Petoumenos | |
| Matthew G Law | |||
| Darren Russell | |||
| Australian HIV Observational Database | |||
| Kerrie Watson | |||
| Hamish McManus | |||
| Catherine C O'Connor | |||
| Jennifer Broom | |||
| Phillip J Read | |||
| Norman Roth | |||
| P2860 | cites work | Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 |
| Impact of diabetes and gender on survival after acute myocardial infarction in the Province of Quebec, Canada--a population-based study. | Q51631202 | ||
| Rates of combination antiretroviral treatment change in Australia, 1997-2000 | Q74283675 | ||
| HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population | Q80590443 | ||
| Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway | Q94466099 | ||
| Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals | Q22242705 | ||
| Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
| The TREAT Asia HIV Observational Database: baseline and retrospective data | Q30981390 | ||
| Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States | Q33499962 | ||
| AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment | Q33888740 | ||
| Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes | Q34355350 | ||
| A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team | Q34438252 | ||
| HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis | Q34554560 | ||
| Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). | Q34762935 | ||
| CD4 cell responses to combination antiretroviral therapy in patients starting therapy at high CD4 cell counts | Q35175359 | ||
| Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults | Q35214935 | ||
| Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study | Q35316315 | ||
| CD4+ T-cell counts and plasma HIV-1 RNA levels beyond 5 years of highly active antiretroviral therapy | Q35800805 | ||
| Long term management of people with HIV. | Q37628470 | ||
| The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology | Q37869306 | ||
| Determinants of survival in HIV-positive patients | Q38500305 | ||
| The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy | Q38959208 | ||
| Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group | Q43898486 | ||
| Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study. | Q44256226 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | e48839 | |
| P577 | publication date | 2012-11-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy | |
| P478 | volume | 7 |
| Q33931214 | A cell-penetrating antibody fragment against HIV-1 Rev has high antiviral activity: characterization of the paratope |
| Q35149475 | A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. |
| Q43538936 | A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization |
| Q40049903 | Advantages of Chinese medicine for patients with acquired immunodeficiency syndrome in rural central China |
| Q30934548 | An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study |
| Q35743271 | Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD) |
| Q35189562 | Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study |
| Q28553516 | Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy |
| Q35036409 | Co-morbidity, ageing and predicted mortality in antiretroviral treated Australian men: a quantitative analysis |
| Q37086478 | Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV. |
| Q37695051 | Determinants of viremia copy-years in people with HIV/AIDS after initiation of antiretroviral therapy |
| Q53819020 | Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men. |
| Q34455423 | Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? |
| Q89100984 | Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality |
| Q52604630 | Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV. |
| Q56911620 | Expert consensus statement on the science of HIV in the context of criminal law |
| Q28072795 | HIV and COPD: a conspiracy of risk factors |
| Q36946140 | HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD). |
| Q40441188 | HIV-Related Stress and Life Chaos Mediate the Association Between Poverty and Medication Adherence Among People Living with HIV/AIDS. |
| Q36656015 | Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men. |
| Q91638984 | How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy |
| Q33824893 | How does specialist nursing contribute to HIV service delivery across England? |
| Q35951760 | Improved survival in HIV treatment programmes in Asia |
| Q91749855 | Incidence and predictors of second-line antiretroviral treatment failure among adults living with HIV in Amhara region: a multi-centered retrospective follow-up study |
| Q64111789 | Incidence and time trends of anal cancer among people living with HIV in Australia |
| Q36360961 | Joint analysis of longitudinal and survival AIDS data with a spatial fraction of long-term survivors: A Bayesian approach |
| Q35753540 | Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar. |
| Q28555157 | Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study |
| Q35894666 | Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins |
| Q61797329 | Prevalence and factors associated with emotional and behavioural difficulties among children living with HIV in Malawi: a cross-sectional study |
| Q64969081 | Pyrimidine 2,4-Diones in the Design of New HIV RT Inhibitors. |
| Q59354287 | Racial/Ethnic Disparities in Failure to Initiate HIV Care: Role of HIV Testing Site, Individual Factors, and Neighborhood Factors, Florida, 2014-2015 |
| Q34804309 | Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region |
| Q57794508 | Risky behaviours and their correlates among adolescents living with HIV in sub-Saharan Africa: a systematic review |
| Q38673536 | Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis |
| Q54239389 | Role of Country of Birth, Testing Site, and Neighborhood Characteristics on Nonlinkage to HIV Care Among Latinos. |
| Q61817334 | Socio-demographic, clinical, and psychosocial factors associated with primary caregivers' decisions regarding HIV disclosure to their child aged between 6 and 12 years living with HIV in Malawi |
| Q64128870 | Survival and associated factors among people living with HIV/AIDS: A 30-year national survey in Iran |
| Q38401028 | Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies |
| Q42274827 | Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011). |
| Q38153101 | The contribution of the HIV specialist nurse to HIV care: a scoping review |
| Q57784862 | Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia |
| Q41659730 | Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus |
Search more.